Phospholipids against American foulbrood and European foulbrood in honeybees
New treatment concept against two devastating honeybee larval diseases, i.e., American and European foulbrood (AFB, EFB), based on the natural compound lysophosphatidylcholine (LPC). LPC exhibits strong antibacterial activity against the causative agents of AFB and EFB and LPC supplementation to honeybee larvae was proven to reduce the outbreak of AFB significantly. The utilization of an LPC based therapy contributes to improve environmental sustainability in honeybee health and may offer new business perspectives in veterinary medicine.
Further information: PDF
Wissenstransferzentrum Süd (WTZ Süd)
Phone: +43(0)316-873 6925
Contact
Moritz Theisen
As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Going Green: Fighting Freshwater Salt Pollution with Phytoremediation
Salt pollution in freshwater is a growing global concern. Excessive salt harms plants, degrades soil, and compromises water quality. In urban areas, road salts used for de-icing during winter often…
Psoriasis Patients at Increased Risk for Crohn’s Due to Gut Inflammation
People with the skin condition psoriasis often have invisible inflammation in the small intestine with an increased propensity for ‘leaky gut’, according to new research at Uppsala University. These changes…
Popular Weight-Loss Drugs—Beneficial or Risky?
GLP-1 medications tied to decreased risk of dementia, addiction; increased risk of kidney, pancreas and gastrointestinal problems Growing Public Demand for GLP-1RA Weight-Loss Medications Demand for weight-loss medications sold under…